Table 1.

Baseline Demographic and Clinical Characteristics For Individuals Randomized to Receive 4 g a day of Omega-3 and Placebo.

Demographic		Placebo	4g/day Omega 3
		(n = 10)	(n = 11)
-Age [Mean (SD)]		51.50 (13.13)	43.45 (14.74)
-Sex [N, %]	Female	8, 80%	7, 64%
	Male	2, 20%	4, 36%
-Race [N, %]	Black/African-American	5, 50%	5, 46%
	Asian	0, 0%	1, 9%
	Caucasian	4, 40%	4, 36%
	Unknown/Not Reported	1, 10%	1, 9%
-Ethnicity [N, %]	Hispanic	3, 30%	1, 9%
	Not Hispanic	7, 70%	10, 91%
-Education [N, %]	High School or Less	2, 20%	1, 9%
	Some College or More	8, 80%	10, 91%
-Marital Status [N, %]	Married/Living Together	1, 10%	3, 28%
	Separated/Divorced/Widowed	5, 50%	4, 36%
	Never Married	4, 40%	4, 36%
Clinical Characteristics
IDS-C30 Score [Mean (SD)]		36.60 (10.54)	31.55 (4.97)
CRP mg/L [Median (IQR Range)]ⴕ		6.9 (4.55)	3.86 (4.71)
Body Mass Index [Median (IQR) Range]		40.78 (7.02)	35.14 (4.97)
CPFQ: Lower-order Cognitive Subscale		11.30 (2.63)	11.73 (1.95)
CPFQ: Higher-order Cognitive Subscale		14.10 (3.51)	11.64 (2.42)

ⴕ = difference in median values estimated using Kruskal Wallis Test; CPFQ = Cognitive Physical Functioning Questionnaire.